...
首页> 外文期刊>Acta ophthalmologica >The area of fixation covaries with short‐term changes in visual acuity after anti‐vascular endothelial growth factor treatment in patients with diabetic macular oedema
【24h】

The area of fixation covaries with short‐term changes in visual acuity after anti‐vascular endothelial growth factor treatment in patients with diabetic macular oedema

机译:糖尿病黄鼠水肿患者抗血管内皮生长因子治疗后视力短期变化的固定协变量

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Purpose Diabetic maculopathy can be treated with intravitreal injection of vascular endothelial growth factor ( VEGF ) inhibitors. However, the therapy is not effective in all patients, and it would be desirable to have parameters for differentiating patients who will benefit from treatment from those who will not. Retinal fixation has been shown to be impaired in patients with low visual acuity (VA) secondary to macular disease, but the changes in fixational eye movements after anti‐ VEGF treatment for diabetic maculopathy have not been investigated. Methods Retinal fixation was studied in 29 patients with diabetic macular?oedema before three monthly anti‐ VEGF injections, and 1 and 4?months after the last injection. The change in VA was correlated with changes in area, frequency, amplitude and total number of fixational saccades. Results During three monthly injections, best‐corrected visual acuity ( BCVA ) increased from (mean?±? SD ) 74.0?±?11.5 Early Treatment Diabetic Retinopathy Study ( ETDRS ) letters to 78.3?±?9.8 ETDRS letters, (p?=?0.003) and central retinal thickness ( CRT ) decreased from (mean?±? SD ) 441.7?±?107.0? μ m to 339.5?±?74.2? μ m, (p?=?0.0001), which was followed by the opposite changes after treatment ( BCVA reduced nonsignificantly to 77.5?±?10.4 ETDRS letters (p?=?0.06), and CRT increased to 393.0?±?9.8? μ m, p?=?0.0001). Both improvement and worsening of BCVA correlated with the fixation area ( r 2 ?=?0.28, p?=?0.003 and r 2 ?=?0.14, p?=?0.045, respectively), but only improvement of BCVA correlated with the frequency ( r 2 ?=?0.15, p?=?0.037) and total number of saccades ( r 2 ?=?0.18, p?=?0.02). BCVA showed no correlation with the amplitude and most frequently occurring saccade amplitude. Conclusion Fixational eye movements may be used to monitor short‐term effects of anti‐ VEGF treatment on diabetic macular oedema. Future studies should aim at investigating a possible predictive value of fixational eye movements for visual function in the long term.
机译:摘要目的目的糖尿病患者可以用腔内注射血管内皮生长因子(VEGF)抑制剂治疗。然而,治疗在所有患者中都不有效,并且希望具有用于区分将从不会受益于不会受益的患者的参数。已经显示过视网膜固定在低视力(VA)中的患者患者患者患者患者,但尚未研究抗VEGF治疗后的抗VEGF治疗后的固定眼动作的变化。方法在29例糖尿病黄斑患者中研究了视网膜固定,在三个月的抗VEGF注射之前的水肿,1和4个月后,最后一次注射后数月。 VA的变化与区域,频率,幅度和固定扫描总数的变化相关。结果在三次每月注射期间,最佳校正的视力(BCVA)从(平均值?±3)增加74.0?±11.5早期治疗糖尿病视网膜病变研究(ETDRS)字母到78.3?±9.8 ETDRS字母,(P?= ?0.003)和中央视网膜厚度(CRT)降低(平均值α±sd)441.7?±107.0? μm至339.5?±74.2? μm,(p?=Δ<0.0001),然后进行处理后的相反变化(BCVA无显着减少到77.5?±10.4 etdrs字母(p?= 0.06),并且CRT增加到393.0?±±± 9.8?μm,p?=Δ= 0.0001)。 BCVA的改善和恶化与固定区域相关(R 2?= 0.28,P?= 0.003和R 2?=?0.14,P?=?0.045),但仅改善BCVA与频率相关(R 2?=?0.15,p?= 0.037)和扫视总数(r 2?= 0.18,p?= 0.02)。 BCVA显示与幅度和最频繁发生的扫描幅度没有相关性。结论固定眼球运动可用于监测抗VEGF治疗对糖尿病黄斑水肿的短期影响。未来的研究旨在在长期调查视觉功能的可能预测值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号